HeraMED (ASX:HMD) strikes a deal with Joondalup Health Campus

Highlights Joondalup Health Campus (JHC) will adopt the complete HeraCARE solution for its audience. It is the first commercial roll out of the HeraMED technology. HeraMED began collaborating with JHC in 2020 via a clinical trial. Manufac...

Nyrada (ASX:NYR) boasts of robust cash position of A$11.1M

Highlights Nyrada shares its Quarterly Activities Report along with a summary of progress for its Cholesterol-Lowering and Brain Injury Programs. As of 31 December 2021, the company reported a strong cash position of AU$11.1 million. Nyrada re...

All you need to know about biohacking

Highlights Biohacking refers to the application of hacker ethics for improving one's body and wellbeing. Nutrigenomics focuses on the interface between one’s genetic materials and the food they eat. In 2004, the US FDA granted approval t...

From Emyria to Starpharma: Latest updates on 5 ASX healthcare stocks

The ASX healthcare sector includes pharmaceutical, biotechnology companies, food and drug retailers, healthcare providers, and medical equipment suppliers. The sector has gained traction in the recent times owing to the increased demand of medical ...

Australia's healthtech firm ImExHS (ASX:IME) launches Aquila in Thai market

  • Jan 20, 2022 AEDT
  • Samta

The leading Australian medical imaging software provider ImExHS Limited’s shares (ASX:IME) closed in green as the company announced to received Thai FDA approval. As per the release, IME has spread its wings in the Thai market after getting ...

Virtus Health (ASX:VRT) gets A$650M buyout offer from CapVest

Highlights  Virtus receives a proposal from CapVest concerning its acquisition at an offer price of AU$7.60 cash per share. The proposal offered by CapVest tops another AU$607 million takeover offer proposed by BGH Capital to Virtus Health...

EVE Health’s (ASX:EVE) subsidiary reports A$750K unaudited revenue in H1 FY22

Highlights EVE Health’s subsidiary Meluka Australia records AU$750,000 unaudited revenue in H1 FY22.  Meluka has already launched a new Collagen Probiotic Concentrate drink and is expecting to launch four new probiotic products by th...

A future insight into global healthcare

Highlights Thanks to the emergence of newer tech innovations by the day, the healthcare industry can expect fresh and enhanced systems for quicker diagnosis and better treatment in the years ahead. Artificial intelligence (AI) has developed to ...

ResAPP Health (ASX:RAP) to launch ResAppDx in Philippines

ResApp Health Limited (ASX:RAP), a digital health company focused on respiratory diseases, advised that the company has signed a deal with Homify to launch ResAppDx in the Philippines. Despite the positive news, there was no movement in the RAP sh...

Little Green Pharma (ASX:LGP) signs exclusive oils distribution deal with AMP

Highlights Little Green Pharma signs a distribution agreement with AMP Medical to distribute LGP cannabis oils in Germany. AMP has agreed to distribute and market LGP cannabis oil medicines solely and not promote any other oil products in Germa...